* CARBIDOPA/LEVODOPA/ENTACAPONE
Stalevo Drug Information
Available in several doses, Stalevo is a formulation of three different pharmacological agents that is used in the treatment of Parkinson’s disease. This generic medication may be used as replacement for immediate release preparations or in the management of those patients who demonstrate “wearing-off” effects associated with the end of the drug dosage. For such patients (with “wearing-off”), however, the use of this medication must follow a through medical examination as there are dose and clinical criteria that must be fulfilled. Since this medication contains three different drugs, the overall effect of the medication is brought about the cumulative action of each of the three component drugs.
Stalevo Dosage Information
Carbidopa/ Levodopa/ Entacapone are the three components of this medication. Although the formulation is available in different doses, the basic proportion of each of the drug remains constant. For every 1 part of Carbidopa, 4 parts of Levodopa are added. 200 mg of Entacapone is added to each preparation as a standard. The recommended dose varies for each patient and therefore tends to be individualized. Dose must be titrated for each patient after careful evaluation by a physician. Cheap Stalevo may be purchased in doses of 12.5 mg/50 mg/200 mg (Stalevo 50), 18.75 mg/75 mg/200mg (Stalevo 75), 25 mg/100 mg/200 mg (Stalevo 100), 31.25 mg/125 mg/200 mg (Stalevo 125), 37.5 mg/150 mg/200 mg (Stalevo 150) and 50 mg/200 mg/ 200 mg (Stalevo 200). Order great discount Stalevo on North Meds.
Side Effects and Precautions for Stalevo
Frequently, side effects like dyskinesia, nausea, chest pain, orthostatic hypotension, agranulocytosis, leukopenia, back pain, dizziness, shoulder pain and insomnia have been reported with the use of this Carbidopa/ Levodopa/ Entacapone preparation. Potential psychotic effects could be seen in patients consuming this drug, therefore patients who buy Stalevo for use must be cautious and under supervision.A condition mimicking Neuroleptic Malignant Syndrome has also known to occur in those patients in whom Stalevo use has been stopped suddenly.
* All trademarks and registered trademarks are the property of their respective owners.
